MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet

AbbVie Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f8738cbadb548558
Product Name: MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet
Artg Id: 352573
Artg Name: MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet
Sponsor: AbbVie Pty Ltd
Company Detail Path: /organization/abbvie-pty-ltd
Artg Date: 2022-02-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/e0186bd6e96d38804e509f377c5fb411.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/9a040e456036049ca312b1c60c01f043.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f8738cbadb548558

Type

Standard